Treatment of preeclampsia, toxemia and preterm labor with...

Details Treatment of preeclampsia, toxemia and preterm labor with... Treatment of preeclampsia, toxemia and preterm labor with...

2005-01-18

2005-01-18

Lilling, Herbert J. (Department: 1651)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S012200, C514S108000, C514S171000, C514S177000, C514S178000, C514S179000, C514S180000, C514S181000, C514S182000, C514S232500, C514S241000, C514S253030, C514S254080, C514S261100, C514S263370, C514S284000, C514S307000, C514S412000, C514S509000, C514S561000, C514S562000, C514S565000, C514S548000, C514S608000, C514S651000, C514S652000, C514S742000

Reexamination Certificate

active

06844320

ABSTRACT:
Preeclampsia and preterm labor in a pregnant female mammal are treated by administering thereto a combination of a progestin and a nitric oxide synthase substrate, a nitric oxide donor or both, optionally in further combination with one or more of a cyclooxygenase inhibitor, a PGI2-mimetic, a thromboxane (TXA2) inhibitor, a compound possessing TXA2-agonistic and TXA2-inhibiting properties, a compound possessing TXA2-antagonistic and PGI2-memetic activities, and a TXA2antagonist.

REFERENCES:
patent: 4855142 (1989-08-01), Fankhauser et al.
patent: 5217997 (1993-06-01), Levere et al.
patent: 5508045 (1996-04-01), Harrison et al.
patent: 441119 (1991-08-01), None

Affiliated with

Also associated with

Rating

Treatment of preeclampsia, toxemia and preterm labor with... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of preeclampsia, toxemia and preterm labor with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of preeclampsia, toxemia and preterm labor with... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3389720